Screening for SF3B1 mutations is a useful tool to differentiate between acquired clonal and non-clonal sideroblastic anemia

Leuk Lymphoma. 2015 Jun;56(6):1888-90. doi: 10.3109/10428194.2014.976821. Epub 2014 Nov 14.

Authors

Valeria Visconte¹, Ali Tabarroki, Christopher J Gerace, Karam Al-Issa, Eric D Hsi, Heesun J Rogers, Mikkael A Sekeres, Bernard J Silver, Alan E Lichtin, Sudipto Mukherjee, Ramon V Tiu

Affiliation

¹ Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic , Cleveland, OH , USA.

PMID: 25330446
DOI: 10.3109/10428194.2014.976821

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Aged
Anemia, Sideroblastic / classification
Anemia, Sideroblastic / diagnosis
Anemia, Sideroblastic / genetics*
Child
DNA Mutational Analysis
Diagnosis, Differential
Female
Genetic Testing / methods*
Humans
Male
Middle Aged
Mutation*
Phosphoproteins / genetics*
RNA Splicing Factors
Ribonucleoprotein, U2 Small Nuclear / genetics*
Sensitivity and Specificity
Young Adult

Substances

Phosphoproteins
RNA Splicing Factors
Ribonucleoprotein, U2 Small Nuclear
SF3B1 protein, human